Departmen of Nutrition, Exercise and Sports
Copenhagen, Denmark
NCT Number: NCT06105476
The aims of this study are two-fold. First to investigate the influence of protein on the FGF21 response induced by alcohol, and second to investigate the influence of retinol on FGF21 concentrations and the FGF21 response induced by alcohol. Exploratory, and in order to investigate mechanisms behind the potential influence on alcohol-induced FGF21 response from protein or retinol intake, plasma glucose, insulin, glucagon, ethanol, acetaldehyde, acetate, retinol, retinoic acid, as well as subjective rating of appetite, will be measured.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Copenhagen, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Test drink with 12 g alcohol (30 g vodka 40%) in water
Test drink with 12 g alcohol (30 g vodka 40%) and 25 g whey protein in water
Test drink with 12 g alcohol (30 g vodka 40%) and 1000 μg retinol in water
Test drink with 1000 μg retinol in water
Time frame: Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks.
Time*drink interaction and iAUC
Time frame: Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks.
Time*drink interaction and iAUC
Time frame: Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks.
Time*drink interaction and iAUC
Time frame: Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks.
Time*drink interaction and iAUC
University of Copenhagen
Other
Acronym: FGF21-APA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details